nhia logo

Quick Links
Search NHIA.org



Baczewski D. Non-compliance is not an option—Strengthening USP <797> compliance through proper clean room maintenance. 2013;19(6):22-25.

Bickley S. USP compliance: A journey. 2006. 12(5):32-6.

Counce J. Digging deep: Infusion pharmacies bear the cost of USP <797> compliance. 2006:12(1):15-9.

Counce J. FDA Inspections—preparing and protecting your home infusion pharmacy. 2016;22(6):25-26.

Dillon LR. Questions (and Answers) About Hazardous Drugs in Sterile Compounding. 2016;22(6):28-32.

Douglass K, Kastango E, and Canto P. Sterile Compounding and USP <797> Compliance: Where Does the Alternate-Site Pharmacy Setting Stand? 2012; 18(2):21-28.

Douglass K, and Kastango E. and Cantor P. The 2011 United States Pharmacopeia Chapter <797> Compliance Study: Discussion of Findings and Strategies for Improvement in the Alternate-Site Setting. 2012; 18(3):38-44.

Filibeck D and Counce J. It’s not just about the stickers: Building a positive relationship with a certifier is key to maintaining a state of aseptic control in your cleanroom. 2014;20(6):25-32.

Kaplan LK. Building a clean room: Words of wisdom. 1995;1(11):19-20.

Kaplan LK. In New Jersey: A step beyond. 1995;1(11):22-27.

Kaplan LK. How clean is clean enough? 1995;1(11):11-18.

Kaplan LK. Filtration: An overview. 1996;3(1):29-32.

Kastango ES and Bradshaw B. Sterile product compounding: Developing quality-based standards for pharmacy practice. 2003;9(1):23-7.

Kastango ES. USP <797>: Making the case for increasing environmental controls in pharmaceutical compounding. 2005.11(4):S1-S12.

Kastango E. USP chapter <797>: The next phase. 2006. 12(4):25-9.

Kastango E. Maintaining a state of control in sterile compounding—The intersection of professional responsibility and patient safety. 2013;19(6):28-35.

Nowobilski-Vasilios A. State of the union—Sterile compounding: Overview of state legislative changes related to sterile preparation. 2014;20(6):19-24.

NHIA.  New national standards on pharmaceutical compounding. 2004;10(1):20-2.

Petroff B and Baczewski D. Blueprint for Patient Safety: How informed clean room design can promote sterility. INFUSION.2015;21(6):27-33.

Rahe H. Barrier/isolation technology: An alternative to the clean room. 1996;2(11):34-38.

Sullivan C. Sterile Compounding in the Future: How Newly Proposed USP Standards Could Affect Your Practice. INFUSION.2015;21(6):22-25.

Sullivan C. Maintaining a Controlled Environment: Cleaning and disinfecting in the clean room. INFUSION.2015;21(6):36-43.

Wagner JT. Interpreting cleanroom certification reports: What providers should know to ensure compliance. 2014;20(6):34-41.